Weighted Average Number of Shares Outstanding, Diluted of NEVRO CORP from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NEVRO CORP quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • NEVRO CORP Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2024 was 37,088,476, a 3.1% increase year-over-year.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 37,088,476, a 3.1% increase from 2023.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 35,981,431, a 1.3% increase from 2022.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 35,525,255, a 2% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

NEVRO CORP Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 37,088,476 +1,107,045 +3.1% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 37,324,907 +1,182,652 +3.3% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 36,936,867 +1,015,328 +2.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 36,467,371 +882,686 +2.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 35,981,431 +456,176 +1.3% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 36,142,255 -1,196,690 -3.2% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 35,921,539 +603,773 +1.7% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 35,584,685 +510,823 +1.5% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 35,525,255 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
Q3 2022 37,338,945 +2,460,502 +7.1% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 35,317,766 +509,377 +1.5% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 35,073,862 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023 2023 Q1
Q3 2021 34,878,443 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 34,808,389 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2

NEVRO CORP Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 37,088,476 +1,107,045 +3.1% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 35,981,431 +456,176 +1.3% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 35,525,255 +701,997 +2% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 34,823,258 +1,145,617 +3.4% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 33,677,641 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.